UK markets open in 5 hours 21 minutes
NIKKEI 225
37,984.06 -245.05 (-0.64%) HANG SENG
18,904.58 -59.10 (-0.31%) CRUDE OIL
77.82 -0.44 (-0.56%) GOLD FUTURES
2,362.20 -12.80 (-0.54%) DOW
39,512.84 +125.04 (+0.32%) Bitcoin GBP
48,977.63 +349.30 (+0.72%)
GILD Jan 2026 50.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:41PM EDT. Market open.
| Previous close | 2.8000 |
| Open | 2.5700 |
| Bid | 2.4200 |
| Ask | 2.7500 |
| Strike | 50.00 |
| Expiry date | 2026-01-16 |
| Day's range | 2.5700 - 2.5900 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.15k |
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
© 2024 Yahoo. All rights reserved.